How Psilocybin Can Rewire Our Brain, Its Therapeutic Benefits & Its Risks

In this episode, I discuss what psilocybin is (chemically) and how it works at the cellular and neural circuit level to trigger neuroplasticity, which is our brain’s ability to rewire itself in ways that lead to long-lasting shifts in our emotional, cognitive and behavioral patterns and abilities. I discuss the emerging clinical trial evidence for the use of psilocybin in the treatment of depression, addictions and other psychiatric challenges. I explain the typical duration and phases of a psilocybin journey, the different categories of dosages often used and I explain the importance of set, setting and support when using psychedelics. I explain which groups of people place themselves at great risk by taking psilocybin as well as groups that could benefit, and I highlight the rapidly changing legal and medical landscape around psilocybin. This episode is a thorough exploration of psilocybin from the scientific and clinical literature perspective and ought to be of interest to anyone curious about psilocybin, mental health, neuroplasticity and/or psychedelics more generally.

#HubermanLab #Science

Thank you to our sponsors

AG1 (Athletic Greens)

Eight Sleep

HVMNcode“Huberman”

Supplements from Momentous

Social & Website

Articles

The neural basis of psychedelic action

The effects of psilocybin and MDMA on betweennetwork resting state functional connectivity in healthy volunteers

Increased lowfrequency brain responses to music after psilocybin therapy for depression

Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for TreatmentResistant Depression

Brief structured respiration practices enhance mood and reduce physiological arousal

Therapeutic use of psilocybinPractical considerations for dosing and administration

Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo

Psychedelics and NeuroplasticityA Systematic Review Unraveling the Biological Underpinnings of Psychedelics

SingleDose Psilocybin for a TreatmentResistant Episode of Major Depression

Effects of PsilocybinAssisted Therapy on Major Depressive Disorder